BMS’ Opdivo joins the perioperative lung cancer treatment ring with key FDA approval zbecker Thu, 10/03/2024 – 15:24 More: BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval Source: fierce
read moreNHS England proposes phased rollout for Eli Lilly’s star obesity drug kdunleavy Thu, 10/03/2024 – 14:47 More: NHS England proposes phased rollout for Eli Lilly's star obesity drug Source: fierce
read moreFerring opens doors to Finnish manufacturing hub as supply of its bladder cancer gene therapy continues to grow fkansteiner Thu, 10/03/2024 – 12:12 More: Ferring opens doors to Finnish manufacturing hub as supply of its bladder cancer gene therapy continues
read moreArgenx widens its Halozyme Therapeutics-partnered net with 4 new targets in $30M license expansion zbecker Thu, 10/03/2024 – 10:54 More: Argenx widens its Halozyme Therapeutics-partnered net with 4 new targets in M license expansion Source: fierce
read moreEliem Therapeutics mounts corporate rebrand after pipeline overhaul, mass layoffs apark Thu, 10/03/2024 – 10:50 More: Eliem Therapeutics mounts corporate rebrand after pipeline overhaul, mass layoffs Source: fierce
read more
Phase 1 trial of IRL757 demonstrates good absorption and safety profile More: IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals